XBiotech shares tank after PhIII data get a roasting
The last time we checked in with Austin-based XBiotech $XBIT, the company was trying to explain how it had screwed up a Phase III study …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
